1 year return (CAGR)
113.83%
Travere Therapeutics Inc Exchange (NASDAQ, USD)
TVTX
59.83
-2.10 (-4.69%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
39.69%
5 year return (CAGR)
11.53%
10 year return (CAGR)
11.68%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
3.94B
Price/Sales
8.03
Ent value
4.34B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
8.75
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 45.93 |
| Daily high | 45.97 |
| Daily low | 42.18 |
| Daily Volume | 9.89M |
| All-time high | 675.00 |
| 1y analyst estimate | 74.14 |
| Beta | 1.04 |
| EPS (TTM) | -0.47 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| TVTX | S&P500 | |
| Current price drop from All-time high | -91.14% | -1.29% |
| Highest price drop | -99.97% | -56.47% |
| Date of highest drop | 10 Dec 2008 | 9 Mar 2009 |
| Avg drop from high | -93.42% | -10.68% |
| Avg time to new high | 682 days | 12 days |
| Max time to new high | 4086 days | 1805 days |
News
